Matches in SemOpenAlex for { <https://semopenalex.org/work/W2749021728> ?p ?o ?g. }
- W2749021728 endingPage "105" @default.
- W2749021728 startingPage "97" @default.
- W2749021728 abstract "Oral immunotherapy has attracted much interest as a potential treatment for food allergy, yet little is known about its long-term effects. We aimed to assess long-term outcomes in participants who completed a randomised, double-blind, placebo-controlled trial of combined probiotic and peanut oral immunotherapy (PPOIT), which was previously shown to induce desensitisation and 2-week sustained unresponsiveness.All participants who completed the PPOIT randomised trial were eligible to participate in this follow-up study 4 years after treatment cessation. Peanut intake and adverse reactions to peanut in the 4 years after treatment cessation were systematically documented with a structured questionnaire administered by allergy nurses. Additionally, participants were invited to undergo peanut skin prick tests, measurement of peanut sIgE and sIgG4 concentrations, and double-blind placebo-controlled peanut challenge to assess 8-week sustained unresponsiveness.48 (86%) of 56 eligible participants were enrolled in the follow-up study. Mean time since stopping treatment was 4·2 years in both PPOIT (SD 0·6) and placebo (SD 0·7) participants. Participants from the PPOIT group were significantly more likely than those from the placebo group to have continued eating peanut (16 [67%] of 24 vs one [4%] of 24; absolute difference 63% [95% CI 42-83], p=0·001; number needed to treat 1·6 [95% CI 1·2-2·4]). Four PPOIT-treated participants and six placebo participants reported allergic reactions to peanut after intentional or accidental intake since stopping treatment, but none had anaphylaxis. PPOIT-treated participants had smaller wheals in peanut skin prick test (mean 8·1 mm [SD 7·7] vs 13·3 mm [7·6]; absolute difference -5·2 mm [95% CI -10·3 to 0·0]; age-adjusted and sex-adjusted p=0·035) and significantly higher peanut sIgG4:sIgE ratios than placebo participants (geometric mean 67·3 [95% CI 10·3-440·0] vs 5·2 [1·2-21·8]; p=0·031). Seven (58%) of 12 participants from the PPOIT group attained 8-week sustained unresponsiveness, compared with one (7%) of 15 participants from the placebo group (absolute difference 52% [95% CI 21-82), p=0·012; number needed to treat 1·9 [95% CI 1·2-4·8]).PPOIT provides long-lasting clinical benefit and persistent suppression of the allergic immune response to peanut.Murdoch Childrens Research Institute and Australian Food Allergy Foundation." @default.
- W2749021728 created "2017-08-31" @default.
- W2749021728 creator A5003961145 @default.
- W2749021728 creator A5004596075 @default.
- W2749021728 creator A5010219015 @default.
- W2749021728 creator A5011316528 @default.
- W2749021728 creator A5029848786 @default.
- W2749021728 creator A5043315856 @default.
- W2749021728 creator A5051304377 @default.
- W2749021728 creator A5072887144 @default.
- W2749021728 creator A5073883447 @default.
- W2749021728 creator A5076307347 @default.
- W2749021728 creator A5085432733 @default.
- W2749021728 date "2017-10-01" @default.
- W2749021728 modified "2023-10-18" @default.
- W2749021728 title "Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trial" @default.
- W2749021728 cites W1594531404 @default.
- W2749021728 cites W1859784730 @default.
- W2749021728 cites W1896084611 @default.
- W2749021728 cites W1963754158 @default.
- W2749021728 cites W1969953062 @default.
- W2749021728 cites W1973124071 @default.
- W2749021728 cites W1977800771 @default.
- W2749021728 cites W1994832965 @default.
- W2749021728 cites W2001776785 @default.
- W2749021728 cites W2012513978 @default.
- W2749021728 cites W2022764839 @default.
- W2749021728 cites W2024316399 @default.
- W2749021728 cites W2029661050 @default.
- W2749021728 cites W2042492374 @default.
- W2749021728 cites W2046196172 @default.
- W2749021728 cites W2050806871 @default.
- W2749021728 cites W2057706989 @default.
- W2749021728 cites W2058897820 @default.
- W2749021728 cites W2063720477 @default.
- W2749021728 cites W2072535088 @default.
- W2749021728 cites W2074808914 @default.
- W2749021728 cites W2093274439 @default.
- W2749021728 cites W2099297204 @default.
- W2749021728 cites W2101419854 @default.
- W2749021728 cites W2115509572 @default.
- W2749021728 cites W2118587943 @default.
- W2749021728 cites W2140344612 @default.
- W2749021728 cites W2145207858 @default.
- W2749021728 cites W2147172644 @default.
- W2749021728 cites W2148903359 @default.
- W2749021728 cites W2162344297 @default.
- W2749021728 cites W2172057771 @default.
- W2749021728 cites W2278243114 @default.
- W2749021728 cites W2327922071 @default.
- W2749021728 cites W2339956256 @default.
- W2749021728 cites W4244703787 @default.
- W2749021728 cites W4255641154 @default.
- W2749021728 doi "https://doi.org/10.1016/s2352-4642(17)30041-x" @default.
- W2749021728 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30169215" @default.
- W2749021728 hasPublicationYear "2017" @default.
- W2749021728 type Work @default.
- W2749021728 sameAs 2749021728 @default.
- W2749021728 citedByCount "119" @default.
- W2749021728 countsByYear W27490217282017 @default.
- W2749021728 countsByYear W27490217282018 @default.
- W2749021728 countsByYear W27490217282019 @default.
- W2749021728 countsByYear W27490217282020 @default.
- W2749021728 countsByYear W27490217282021 @default.
- W2749021728 countsByYear W27490217282022 @default.
- W2749021728 countsByYear W27490217282023 @default.
- W2749021728 crossrefType "journal-article" @default.
- W2749021728 hasAuthorship W2749021728A5003961145 @default.
- W2749021728 hasAuthorship W2749021728A5004596075 @default.
- W2749021728 hasAuthorship W2749021728A5010219015 @default.
- W2749021728 hasAuthorship W2749021728A5011316528 @default.
- W2749021728 hasAuthorship W2749021728A5029848786 @default.
- W2749021728 hasAuthorship W2749021728A5043315856 @default.
- W2749021728 hasAuthorship W2749021728A5051304377 @default.
- W2749021728 hasAuthorship W2749021728A5072887144 @default.
- W2749021728 hasAuthorship W2749021728A5073883447 @default.
- W2749021728 hasAuthorship W2749021728A5076307347 @default.
- W2749021728 hasAuthorship W2749021728A5085432733 @default.
- W2749021728 hasConcept C126322002 @default.
- W2749021728 hasConcept C142724271 @default.
- W2749021728 hasConcept C168563851 @default.
- W2749021728 hasConcept C1862650 @default.
- W2749021728 hasConcept C197934379 @default.
- W2749021728 hasConcept C202061045 @default.
- W2749021728 hasConcept C203014093 @default.
- W2749021728 hasConcept C204787440 @default.
- W2749021728 hasConcept C207480886 @default.
- W2749021728 hasConcept C27081682 @default.
- W2749021728 hasConcept C2775933838 @default.
- W2749021728 hasConcept C2776027960 @default.
- W2749021728 hasConcept C2778012357 @default.
- W2749021728 hasConcept C2991744798 @default.
- W2749021728 hasConcept C3018710434 @default.
- W2749021728 hasConcept C535046627 @default.
- W2749021728 hasConcept C71924100 @default.
- W2749021728 hasConceptScore W2749021728C126322002 @default.
- W2749021728 hasConceptScore W2749021728C142724271 @default.
- W2749021728 hasConceptScore W2749021728C168563851 @default.